Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0397 USD | +4.61% | +2.58% | +12.15% |
Mar. 28 | Transcript : CV Sciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
Mar. 28 | CV Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2022 | 16.2M | Sales 2023 | 16M | Capitalization | 5.47M |
---|---|---|---|---|---|
Net income 2022 | -9M | Net income 2023 | 3M | EV / Sales 2022 | 0.36 x |
Net Debt 2022 | 917K | Net cash position 2023 | 875K | EV / Sales 2023 | 0.29 x |
P/E ratio 2022 |
-0.44
x | P/E ratio 2023 |
1.77
x | Employees | 43 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.98% |
Latest transcript on CV Sciences, Inc.
1 day | +4.61% | ||
1 week | +2.58% | ||
Current month | -3.17% | ||
1 month | +10.28% | ||
3 months | +11.20% | ||
6 months | +4.47% | ||
Current year | +12.15% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 66 | 14-06-15 | |
Joerg Grasser
DFI | Director of Finance/CFO | 49 | 18-12-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 66 | 14-06-15 | |
Jamie Corroon
BRD | Director/Board Member | 54 | 22-07-20 |
William McCorkle
BRD | Director/Board Member | 56 | 22-10-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.0397 | +4.61% | 92,028 |
24-04-23 | 0.038 | 0.00% | 80,457 |
24-04-22 | 0.038 | -4.65% | 130,784 |
24-04-19 | 0.0398 | +8.09% | 87,266 |
24-04-18 | 0.0368 | -4.73% | 274,474 |
Delayed Quote OTC Markets, April 24, 2024 at 03:25 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+12.15% | 6.48M | |
+25.61% | 660B | |
+24.35% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+12.77% | 219B | |
-9.82% | 196B | |
+6.81% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- CVSI Stock